There was a hint of efficacy with 74% of cell recipients versus 41% of cooled controls having Bayley-III scores >85 in 3 domains; however, this did not reach statistical significance.
← all excerpts
Umbilical Cord Blood and Cord Tissue-Derived Cell Therapies for Neonatal Morbidities: Current Status and Future Challenges.
1
—
—